Exaggerated IL-17A activity in human in vivo recall responses discriminates active tuberculosis from latent infection and cured disease
Gabriele Pollara, Carolin T. Turner, Joshua Rosenheim, Aneesh Chandran, Lucy Bell, Ayesha Khan, Amit A. Patel, Luis Felipe Peralta, Anna Folino, Ayse U. Akarca, Cristina Venturini, Tina Baker, Simone Ecker, Fabio Luigi Massimo Ricciardolo, Teresa Marafioti, César Ugarte‐Gil, David Moore, Benny Chain, Gillian S. Tomlinson, Mahdad Noursadeghi
Abstract
17 differentiation within tissues. Modulation of these cytokine pathways may provide a rational strategy for host-directed therapy in active TB.
Topics & Concepts
Latent tuberculosisIn vivoActive tuberculosisImmunologyTuberculosisMedicineDiseaseMycobacterium tuberculosisImmunopathologyEx vivoPathologyBiologyBiotechnologyTuberculosis Research and EpidemiologyMycobacterium research and diagnosisImmune responses and vaccinations